Latest news with #ASBP
Yahoo
7 days ago
- Business
- Yahoo
Aspire Biopharma provides development update on BUZZ BOMB supplement
Aspire Biopharma (ASBP) announced the brand name BUZZ BOMB and anticipated market launch for its novel sublingual pre-workout supplement. BUZZ BOMB features 50mg of caffeine and is designed to support sustained energy and mental focus, helping athletes and fitness enthusiasts maximize their performance potential. Aspire has commenced initial production of BUZZ BOMB, its single serving pre-workout caffeine supplement utilizing Aspire's patent-pending and proprietary sublingual delivery pre-workout formula is conveniently packaged in a single serving packet for easy on-the-go use. Consumers will have a choice of six BUZZ BOMB flavors, including Tropical Fruit, Mixed Berry, Watermelon, Lemon Lime, Peach Mango, and Mocha Coffee. The Company expects to begin expanded pre-launch consumer testing of this supplement product during the second quarter of 2025. In August, the Company will have a booth and be an event sponsor at two of the largest fitness conferences in the nation where over 50,000 people interested in health, fitness, optimization, nutrition, and overall wellbeing will be able to taste, sample, and experience the BUZZ BOMB pre-workout supplement. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on ASBP: Disclaimer & DisclosureReport an Issue Aspire announces first patient dosed in Phase 1 trial of aspirin formulation Aspire Biopharma files to sell 8.33M shares of common stock for holders Aspire announces IRB approval for in-human trial of aspirin formulation Aspire commences initial production of pre-workout performance supplement Aspire announces Phase 1 trial initiation of high-dose aspirin formulation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
28-05-2025
- Business
- Globe and Mail
Pharma Stock Massively Bid Up Following New Product Announcement
A Pharmaceuticals company based out of Puerto Rico is turning heads so far during Wednesday's premarket hours after the company introduced its new 'BUZZ BOMB' pre-workout supplement and announced it expects to launch in Q3. Traders wasted no time buying up shares of Aspire Biopharma Holdings Inc. (Nasdaq:ASBP), with shares of the micro cap currently bid up at $.4001/share (+77.82%) leading up to the opening bell. It should be an exciting session for this stock! Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspire's technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of "instant absorption" are to provide nearly instant treatment impact and also allows high dose absorption. Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
